Fosaprepitant 71839-0104-01

Package NDC

71839-0104-01

Manufacturer: Be Pharmaceuticals Inc.
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: October 15, 2019
Listing Expires: December 31, 2026
Application: ANDA212309

Need to source Fosaprepitant? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Fosaprepitant Dimeglumine	150 mg/5mL

Drug Class

Cytochrome P450 2C9 Inducers [MoA]Cytochrome P450 3A4 Inducers [MoA]Cytochrome P450 3A4 Inhibitors [MoA]

Selected Package

71839-0104-01Selected

1 VIAL, SINGLE-DOSE in 1 CARTON (71839-104-01) / 5 mL in 1 VIAL, SINGLE-DOSE